$ARCT LUNAR-COV19 COVID-19 vaccine. Phase 2 trial conducted in U.S. and Singapore. Interim data due early 2021. Phase 3 trial to commence 2Q 2021. Phase 1/2 data released December 28, 2020. ARCT-810 Ornithine Transcarbamylase (OTC) deficiency. Phase 1b initiation of dosing announced December 7, 2020. Data due 2021. Am I missing something, this looks a $12.00 stock to me they are working on a covid vaccine, [covid will be over before they get approved if they even do] I have never shorted a stock and am not a bear just wondering whats up?